Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.91% | 159.66 | 0.7% | $1363.45m | |
| PFE | Pfizer Inc. | -0.52% | 33.65 | 0.9% | $1235.79m | |
| BMY | Bristol-Myers Squibb Co. | -0.83% | 61.59 | 1.0% | $869.38m | |
| MRK | Merck & Co., Inc. | -2.23% | 72.96 | 0.7% | $817.25m | |
| ABBV | AbbVie, Inc. | 0.77% | 108.16 | 1.9% | $814.78m | |
| LLY | Eli Lilly & Co. | 0.93% | 205.71 | 1.1% | $789.42m | |
| AZN | AstraZeneca Plc | -0.80% | 48.52 | 1.2% | $515.96m | |
| GSK | GlaxoSmithKline Plc | -2.07% | 33.67 | 0.2% | $264.82m | |
| NVS | Novartis AG | -0.66% | 86.14 | 0.2% | $189.47m | |
| SNY | Sanofi | 0.43% | 46.00 | 0.2% | $169.17m | |
| VTRS | Viatris, Inc. | -0.57% | 14.97 | 0.0% | $143.54m | |
| VERU | Veru, Inc. | -2.73% | 13.89 | 0.0% | $115.71m | |
| CVAC | CureVac NV | 1.96% | 94.80 | 0.0% | $108.35m | |
| VYNE | VYNE Therapeutics, Inc. | -4.94% | 7.50 | 0.0% | $95.25m | |
| NVO | Novo Nordisk A/S | -1.27% | 71.42 | 0.1% | $91.84m |
Company Profile
Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.